<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.6.0//EN//XML?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName art560.dtd?><?SourceDTD.Version 5.6.0?><?ConverterInfo.XSLTName elsevier2nlmx2.xsl?><?ConverterInfo.Version 1?><?origin publisher?><?FILEmeta_HLY5187 xml ?><?FILEmain xml ?><?FILEmain pdf ?><?FILEgr1 jpg ?><?FILEgr2 jpg ?><?FILEgr3 jpg ?><?FILEgr4 jpg ?><?FILEgr5 jpg ?><?FILEfx1 jpg ?><?FILEfx2 jpg ?><?FILEfx3 jpg ?><?FILEfx4 jpg ?><?FILEfx5 jpg ?><?FILEfx6 jpg ?><?FILEmmc1 pdf ?><?FILEsc1 jpg ?><?FILEsi1 svg ?><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Heliyon</journal-id><journal-id journal-id-type="iso-abbrev">Heliyon</journal-id><journal-title-group><journal-title>Heliyon</journal-title></journal-title-group><issn pub-type="epub">2405-8440</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7567930</article-id><article-id pub-id-type="pii">S2405-8440(20)32030-2</article-id><article-id pub-id-type="doi">10.1016/j.heliyon.2020.e05187</article-id><article-id pub-id-type="publisher-id">e05187</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Synthesis, density functional theory (DFT) studies and urease inhibition activity of chiral benzimidazoles</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Aman</surname><given-names>Hasil</given-names></name><email>hasilaman786@gmail.com</email><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><contrib contrib-type="author" id="au2"><name><surname>Rashid</surname><given-names>Naghmana</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au3"><name><surname>Ashraf</surname><given-names>Zaman</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au4"><name><surname>Bibi</surname><given-names>Aamna</given-names></name><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au5"><name><surname>Chen</surname><given-names>Hsin-Tsung</given-names></name><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au6"><name><surname>Sathishkumar</surname><given-names>Nadaraj</given-names></name><xref rid="aff2" ref-type="aff">b</xref></contrib><aff id="aff1"><label>a</label>Department of Chemistry, Faculty of Science, Alama Iqbal Open University, Islamabad 44000, Pakistan</aff><aff id="aff2"><label>b</label>Department of Chemistry, School of Science, Chung Yuan Christian University, Taoyuan 32023, Taiwan</aff></contrib-group><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author. <email>hasilaman786@gmail.com</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>14</day><month>10</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><month>10</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>14</day><month>10</month><year>2020</year></pub-date><volume>6</volume><issue>10</issue><elocation-id>e05187</elocation-id><history><date date-type="received"><day>13</day><month>5</month><year>2020</year></date><date date-type="rev-recd"><day>2</day><month>8</month><year>2020</year></date><date date-type="accepted"><day>5</day><month>10</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 Published by Elsevier Ltd.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder/><license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract id="abs0010"><p>A variety of benzimidazole by the heterocyclization of orthophenylenediamine were synthesized in 69&#x02013;86% yields. The synthesized compounds <bold>3a-f</bold> and <bold>6a-f</bold> were characterized and further investigated as jack bean urease inhibitors. Density functional theory (DFT) studies were performed utilizing the basis set B3LYP/6-31G (d, p) to acquire perception into their structural properties. Frontier molecular orbital (FMO) analysis of all compounds 3a&#x02013;f and 6a-f was computed at the same level of theory to get a notion about their chemical reactivity and stability. The mapping of the molecular electrostatic potential (MEP) over the entire stabilized molecular geometry indicated the reactive centers. They exhibited urease inhibition activity with IC50 between 22 and 99 &#x003bc;M. Compounds containing withdrawing groups on the benzene ring (<bold>3d, 6d</bold>) were not showing significant urease inhibition. The value obtained for <bold>3a, 3b, 3f</bold> had shown their significant urease inhibition for both theoretical and experimental. Notably, the compound having S-configuration (<bold>3a</bold>) (22.26 &#x000b1; 6.2 &#x003bc;M) was good as compared to its R enantiomer <bold>3f</bold> (31.42 &#x000b1; 23.3 &#x003bc;M). Despite this, we elaborated the computational studies of the corresponding compounds, to highlight electronic effect which include HOMO, LUMO, Molecular electrostatic potential (MEP) and molecular docking.</p></abstract><abstract abstract-type="teaser" id="abs0015"><p>Organic chemistry; Pharmaceutical chemistry; Theoretical chemistry, Benzimidazole; Urease inhibition; Density functional theory; HOMO; LUMO; Molecular docking</p></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd>Organic chemistry</kwd><kwd>Pharmaceutical chemistry</kwd><kwd>Theoretical chemistry</kwd><kwd>Benzimidazole</kwd><kwd>Urease inhibition</kwd><kwd>Density functional theory</kwd><kwd>HOMO</kwd><kwd>LUMO</kwd><kwd>Molecular docking</kwd></kwd-group></article-meta></front><body><sec id="sec1"><label>1</label><title>Introduction</title><p id="p0010">Benzimidazoles are well known nitrogen-containing bioactive compounds. They showed a variety of activities including anti-diabetic [<xref rid="bib1" ref-type="bibr">1</xref>], antimicrobial [<xref rid="bib2" ref-type="bibr">2</xref>], antifungal [<xref rid="bib3" ref-type="bibr">3</xref>], antiviral [<xref rid="bib4" ref-type="bibr">4</xref>], anti-cancer activity [<xref rid="bib5" ref-type="bibr">5a,b</xref>] and anthelminthic [<xref rid="bib6" ref-type="bibr">6</xref>]. Recent studies in medicinal chemistry have demonstrated them as potential drug motifs for the pharmaceutical industry [<xref rid="bib7" ref-type="bibr">7</xref>]. They have also well-known applications in chemo-sensing [<xref rid="bib8" ref-type="bibr">8</xref>], fluorescence [<xref rid="bib9" ref-type="bibr">9</xref>], crystal engineering [<xref rid="bib10" ref-type="bibr">10</xref>], corrosion science [<xref rid="bib11" ref-type="bibr">11a,b</xref>] and asymmetric catalysis [<xref rid="bib12" ref-type="bibr">12</xref>]. The bioactivity of drug molecule depends predominantly on their interaction with drug targets, such as proteins, enzymes, nucleic acids and the biological membranes [<xref rid="bib13" ref-type="bibr">13a,b</xref>]. The efficacy and of the imidazole can be impute to its H-bond donor and acceptor ability as well as its binding affinity with metals [<xref rid="bib14" ref-type="bibr">14</xref>] (see <xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>).<fig id="fig1"><label>Figure&#x000a0;1</label><caption><p>Biologically active drug molecules containing benzimidazoles like omeprazole (used for gastroesophageal diseases), pimobendan (vasodilator), albendazole (parasitic worm infestations), tibendazole, (antifungal agent), lansoprazole (Anti acid) and pantoprazole (proton pump inhibitor) [<xref rid="bib1" ref-type="bibr">1</xref>, <xref rid="bib2" ref-type="bibr">2</xref>, <xref rid="bib3" ref-type="bibr">3</xref>, <xref rid="bib4" ref-type="bibr">4</xref>, <xref rid="bib5" ref-type="bibr">5</xref>, <xref rid="bib6" ref-type="bibr">6</xref>, <xref rid="bib7" ref-type="bibr">7</xref>].</p></caption><alt-text id="alttext0015">Figure&#x000a0;1</alt-text><graphic xlink:href="gr1"/></fig></p><p id="p0015">Urease enzymes belongs to a class of hetero-polymeric enzymes. It is found in excess quantities in beans like soya beans, jack beans, and some other plant seeds [<xref rid="bib15" ref-type="bibr">15</xref>]. The active site of urease comprises of two nickel(II) atoms (Ni<sup>+2</sup>) [<xref rid="bib16" ref-type="bibr">16</xref>]. Urease converts urea into NH<sub>3</sub> and carbon dioxide by hydrolysis [<xref rid="bib17" ref-type="bibr">17a,b</xref>]. It has been reported that ureases are responsible for pathogenicity such as stomach cancer, peptic ulceration, hepatic coma and urinary stones [<xref rid="bib18" ref-type="bibr">18</xref>]. Besides in agriculture, high urease activity results in serious environmental and commercial losses by releasing abnormally enormous amounts of NH<sub>3</sub> in atmosphere [<xref rid="bib19" ref-type="bibr">19a,b</xref>]. The detailed mechanism of urease suggested that the nickel atoms are playing key role in their activity [<xref rid="bib20" ref-type="bibr">20</xref>].</p><p id="p0020">Different compounds have been studied for their urease inhibition response [<xref rid="bib21" ref-type="bibr">21</xref>]. However, benzimidazoles as jackbean urease inhibitors and their DFT studies have rarely ever found in the literature. In this context, some chiral derivatives of benzimidazoles of benzimidazoles were synthesized, several quantum chemical descriptors in order to interpret various molecular properties such as electronic structure, stability, reactivity, in the interest of determining how they could have an impact on our understanding of the experimental observations and describing various aspects of chemical binding. Finally, they have been tested for their Jack Bean Urease inhibition activity. The comparative inhibitory activity of the most potent enantiomer was also calculated.</p></sec><sec id="sec2"><label>2</label><title>Experimental</title><sec id="sec2.1"><label>2.1</label><title>General</title><p id="p0025">All chemicals for the synthesis of chiral benzimidazole derivatives (<bold>3a-f</bold> and <bold>6a-f</bold>) and Jack Bean Urease were purchased from Sigma Co. B&#x000fc;chi melting point B-540 was used for measurement of melting points while Nicolet iS10 spectrophotometer was used for IR spectra. The NMRs of all compounds were run on an Advance 400 MHz NMR spectrometer in DMSO and CDCl<sub>3</sub> solutions. EIMS were recorded on JEOL MSR mass spectrometer.</p></sec><sec id="sec2.2"><label>2.2</label><title>Synthesis</title><sec id="sec2.2.1"><label>2.2.1</label><title>General procedure for synthesis of 3a~f</title><p id="p0030">Equimolar amount (0.0073mol) of o-phenylenediamine (different derivatives) and L-lactic acid were taken in 4N HCl (30.0 ml) and refluxed for 6 h. Whereas, reaction was monitored by thin layer chromatography. Reaction mixture was filtered and neutralized by liquid ammonia (NH<sub>4</sub>OH) to get solid product, which is then purified by flash column using 8:2 of eluents n-hexane and ethyl acetate.</p></sec><sec id="sec2.2.2"><label>2.2.2</label><title>General procedure for synthesis of 6a~f</title><p id="p0035">Naproxenoyl chloride (<bold>4a-f</bold>) was prepared according to given procedure [<xref rid="bib22" ref-type="bibr">22</xref>]: 5.0 ml of POCl<sub>3</sub> was added to a solution of 0.01 mol naproxen in 30 ml of <italic>m</italic>-xylene. The reaction mixture was refluxed for 3 h, the settled down and cooled precipitates were filtered off, washed by ether, and on drying gave a colorless crystal (mp 81 &#x000b0;C). Obtained Yield 73 %; <sup>1</sup>H NMR: &#x003b4; ppm = 1.62 (d, 3H, J = 6.6 Hz, CH<sub>3</sub>), 3.84 (q, 1H, J = 6.5, CH), 3.93 (s, 3H, OCH<sub>3</sub>), 7.12&#x02013;7.74 (m, 6H, Ar). <sup>13</sup>CNMR; 17.53 (CH<sub>3</sub>), 46.31(CH), 54.45 (OCH<sub>3</sub>), 106.30, 119.00, 126.13, 126.30, 127.11, 129.01, 129.61, 134.04, 135.20, 157.70, 179.31.</p><p id="p0040">Equimolar quantity of naproxenoyl chloride (<bold>4a-f</bold>) (0.0073 mol) and orthophenylenediame (different derivatives) were taken in 4N HCl (60 ml) were heated underneath reflux for 6 h. Reaction mixture was filtered off and neutralized with NH<sub>4</sub>OH to induce the solid compound, which is then purified by silica gel column.</p></sec><sec id="sec2.2.3"><label>2.2.3</label><title>General procedure for separation of enantiomers 3a, 3f and 6a, 6f</title><p id="p0045">Desired chiral benzimidazole was dissolved (10 mg/L) in the solvent system of the mobile phase (n-hexane: iso-propanol, 95/5). Each sample (20 &#x003bc;l) was then injected into HPLC with the mobile phase including the reverse phase (CH<sub>3</sub>CN/H<sub>2</sub>O) and normal phase (n-hexane/isopropanol). HPLC system comprised of two pumps (an intelligent pump L-200, L-6000 pump), UV-Vis detector L-4200 and an integration system. The chiral stationary phase was LiChroCART 250-4 (S,S)-Whelk-O1 (5 mm) and LiChroCART 250-4 (R,R)-Whelk-O1 (5mm) with (3R,4R)-and (3S,4S)-4-(3,5-dinitrobenzamido)-1,2,3, 4-tetrahydro-phenanthrene as packing materials. The wavelength used for UV-Vis was set at 210 nm while the chromatography was done at room temperature. To separate the racemate, the samples were injected hundreds of times under a given condition. The pure enantiomer was collected, concentrated under a vacuum evaporator to dry and stored [<xref rid="bib23" ref-type="bibr">23</xref>].</p></sec><sec id="sec2.2.4"><label>2.2.4</label><title>General procedure for urease inhibition studies [<xref rid="bib24" ref-type="bibr">24</xref>].</title><p id="p0050">The urease inhibitory activity of synthesized chiral benzimidazoles <bold>3a-f</bold> and <bold>4a-b</bold> was determined by measuring the amount of ammonia produced by the indophenols method described by Weather burn. The reaction mixtures, comprising 20 &#x003bc;L of enzyme (Jack bean urease, 5 U/mL) and 20 &#x003bc;Lof test compounds in 50 lL buffer (100 micro molar urea, 0.01 MK<sub>2</sub>HPO<sub>4</sub>, 1 micro molar EDTA and 0.01 M Lithium dichloride, pH 8.15), were incubated for 10 min, at 37 &#x000b0;C in 96-well plate. Briefly, 40 &#x003bc;L each of phenol reagents (1%, w/v phenol and 0.005%, w/v sodium nitroprusside) and 70 &#x003bc;L of alkali reagent (0.5%, weight by volume NaOH and 0.1% active chloride, sodium hypochloride) were added to each well. The absorbance at 625.0 nm was measured after 30.0 min, using a microplate reader (OPTI Max, Tunable). All these reactions were performed in atriplicate. The urease inhibition activities were calculated according to the following formula:<disp-formula id="ufd1">Urease inhibition activity (%) = (OD<sub>control</sub> &#x02013; OD<sub>sample</sub>&#x000d7;100)/OD<sub>control</sub></disp-formula>Where OD<sub>control</sub> and OD<sub>sample</sub> represents the optical densities in the absence and presence of sample respectively. Thiourea was used as the standard inhibitor for urease inhibition.</p></sec></sec><sec id="sec2.3"><label>2.3</label><title>Characterization</title><sec id="sec2.3.1"><label>2.3.1</label><title>(R or S)-1-(1H-benzo[d] imidazol-2-yl)ethanol (3a and 3f)</title><p id="p0055">(85%), m.p 182 &#x000b0;C, Rf: 0.4 (n hexane: ethyl acetate) 3:1; IR: <italic>&#x02c71;</italic>: 2942 (=C&#x02013;H), 2843 (-CH<sub>3</sub>), 1615 (C=N), 3500 (O&#x02013;H), 3305(N&#x02013;H). <sup>1</sup>HNMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; ppm: 1.52 (s, 3H, CH<sub>3</sub>, J = 6.8 Hz), 4.96 (q, 1H, J = 6.8), 7.3 (m, 4H, Ar&#x02013;H), 12.2 (s, 1H, NH); <sup>13</sup>CNMR, (75 MHz) &#x003b4; ppm: 70 (chiral carbon),141.5 (C=N), 138.9, 115. 123 (Ar); HRMS (ESI): m/z calculated for C<sub>9</sub>H<sub>9</sub>N<sub>2</sub>O [M<sup>+</sup>]; 163.0871, found 163.0874 (M<sup>+</sup> + H).</p></sec><sec id="sec2.3.2"><label>2.3.2</label><title>(&#x000b1;)-1-(6-chloro-1H-benzo[d] imidazol-2-yl) ethanol (3b)</title><p id="p0060">(80%), m.p 233 &#x000b0;C; IR: <italic>&#x02c71;</italic>: 3500 (O&#x02013;H), 1615 (C=N), 3300 5 (NH), 2952 (CH), 2982 (C-H<sub>Ar</sub>), 700 (C&#x02013;Cl). <sup>1</sup>H-NMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; ppm: 1.49 (d, 3H, CH<sub>3</sub>), 1.48&#x02013;1.50 (d, J = 6.8 Hz), 4.92 (q, 1H, CH) 4.91&#x02013;4.93(J = 6.8), 7.75 (d, 1H, Ar), range (d, J = 8 Hz), 7.61 (s, 1H, Ar), 7.14 (d, 1H, Ar), 7.13&#x02013;7.45 (d, J = 8 Hz), 12.2 (s, 1H, NH); <sup>13</sup>CNMR, (75 MHz) &#x003b4; ppm: 70.4 (chiral carbon),143.9 (C=N imidazole), 134.8-112.5 (Ar); HRMS (ESI): m/z calculated for C<sub>9</sub>H<sub>9</sub>ClN<sub>2</sub>O [M<sup>+</sup> + H<sup>+</sup>], 197.0482 found 197.0484.</p></sec><sec id="sec2.3.3"><label>2.3.3</label><title>(&#x000b1;)-1-(6-bromo-1H-benzo[d]imidazol-2-yl)ethanol (3c)</title><p id="p0065">(82%), m.p 193 &#x000b0;C; IR: <italic>&#x02c71;</italic>: 1615(C=N), 3500 (O&#x02013;H), 3320(N&#x02013;H), 1550 (C&#x02013;Br), 1335 (C&#x02013;N).<sup>1</sup>HNMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; ppm: 1.52 (d, 3H, CH<sub>3</sub>), 1.46&#x02013;1.63 (d, J = 6.8 Hz), 4.99 (q, 1H, CH) 4.95&#x02013;5.01 (J = 6.8), 7.66 (d, 2H, Ar), range (s, J = 3.2 Hz),8.08 (d, 2H, Ar), range (d, J = 6.0 Hz), 8.38 (s, 1H, Ar), 12.20 (s, 1H, NH), 3.33 (s, 1H, OH); <sup>13</sup>CNMR, (75 MHz) &#x003b4; ppm: 23.3(CH<sub>3</sub>) 69.8 (chiral carbon),143.5 (C=N imidazole), 134.8-112.5 (Ar); HRMS (ESI): m/z calculated for C<sub>9</sub>H<sub>9</sub>BrN<sub>2</sub>O [M<sup>+</sup> + Na<sup>+</sup>], 262.9796; found, 262.9799.</p></sec><sec id="sec2.3.4"><label>2.3.4</label><title>(&#x000b1;)-1-(6-nitro-1H-benzo[d] imidazol-2-yl)ethanol (3d)</title><p id="p0070">(78%), m.p 186 &#x000b0;C: IR: <italic>&#x02c71;</italic>: 1615 (C=N), 3500 (O&#x02013;H), 3320(N&#x02013;H), 1550 (N&#x02013;O), 1335 (C&#x02013;N). <sup>1</sup>HNMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; ppm: 1.52 (d, 3H, CH<sub>3</sub>), 1.51&#x02013;1.52 (d, J = 6.8 Hz), 4.99 (q, 1H, CH) 4.97&#x02013;5.01 (J = 6.8), 7.66 (d, 2H, Ar), range (d, J = 3.2 Hz), 8.08 (d, 2H, Ar&#x02013;H), range (d, J = 6.0 Hz), 8.38 (s, 1H, Ar&#x02013;H), 12.20 (s, 1H, NH), 3.33 (s, 1H, OH); <sup>13</sup>CNMR, (75 MHz) &#x003b4; ppm: 69.7 (chiral carbon),142.21 (C=N imidazole), 145.0-110.5 (Ar&#x02013;H); HRMS (ESI): m/z calculated for C<sub>9</sub>H<sub>9</sub>N<sub>3</sub>O3 [M<sup>+</sup> + NH<sub>4</sub><sup>+</sup>], 225.0988 found 225.0986.</p></sec><sec id="sec2.3.5"><label>2.3.5</label><title>(&#x000b1;)-1-(6-methyl-1H-benzo[d]imidazol-2-yl)ethanol (3e)</title><p id="p0075">(86%), m.p 195 &#x000b0;C; IR: <italic>&#x02c71;</italic>: 1615 (C=N), 3500 (O&#x02013;H), 3320 (N&#x02013;H), 1335 (C&#x02013;N). <sup>1</sup>HNMR (400 MHz, DMSO) &#x003b4; ppm: 1.51 (d, 3H, CH<sub>3</sub>), 1.47&#x02013;1.49 (d, J = 6.8 Hz), 2.5 (s, 3H, CH<sub>3</sub>) 4.99 (q, 1H, CH) 4.85&#x02013;4.93 (J = 6.8), 7.66 (d, 1H, Ar&#x02013;H), 8.08 (d, 1H, Ar), 8.38 (s, 1H, Ar&#x02013;H), 12.20 (s, 1H, NH), 3.33 (s, 1H, O&#x02013;H); <sup>13</sup>CNMR, (75 MHz) &#x003b4; ppm: 70 (chiral carbon), 141 (C=N imidazole), 138.8, 115.2 (Ar&#x02013;H), 23.2 MHz (CH<sub>3</sub>), 25 (CH<sub>3</sub>); HRMS (ESI): m/z calculated for C<sub>10</sub>H<sub>12</sub>N<sub>2</sub>O [M<sup>+</sup> + Na<sup>+</sup>], 199.0847; found, 199.0847 (M<sup>+</sup> + Na<sup>+</sup>).</p></sec><sec id="sec2.3.6"><label>2.3.6</label><title>(S/R)-1-(2-methoxynaphthalen-6-yl)ethyl)-1-H-benzo[d]imidazole (6a and 6f)</title><p id="p0080">(73%), m.p 212 &#x000b0;C; IR: <italic>&#x02c71;</italic>: 2940 (C=C&#x02013;H), 1615 (C=N), 3320 (N&#x02013;H), 1325 (C&#x02013;O), 2980 (C-H<sub>Ar</sub>). <sup>1</sup>HNMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; ppm: 1.76 (d, 3H, CH<sub>3</sub>), 1.75&#x02013;1.78 (d, J = 6.8 Hz), 3.87 (s, 3H, OCH<sub>3</sub>), 4.48 (q, 1H, CH) 4.95-4.52 (J = 6.8), 7.70 (d, 2H, Ar), range (d, J = 6.2 Hz), 7.26 (d, 2H, Ar), range (d. J = 6.0 Hz), 7.47 (s, 1H, Ar), 7.57 (d, 1H, Ar), range (d, J = 3.2 Hz), 7.04 (d, 1H, Ar), range (d, J = 3.2 Hz), 7.07 (s, 1H, Ar), 7.38 (d, 1H, Ar); <sup>13</sup>CNMR, (75 MHz) &#x003b4; ppm: 70 (chiral carbon),141.5 (C=N imidazole), 152.2-115.3 (Ar); HRMS (ESI): m/z calculated for C<sub>20</sub>H<sub>18</sub>N<sub>2</sub>O [M<sup>+</sup> + H<sup>+</sup>], 303.1497; found, 303.1499.</p></sec><sec id="sec2.3.7"><label>2.3.7</label><title>(&#x000b1;)-6-chloro-2-((R)-1-(2-methoxynaphthalen-6-yl)ethyl)-1H-benzo[d]imidazol (6b)</title><p id="p0085">(70%), m.p 224 &#x000b0;C; IR: <italic>&#x02c71;</italic>: 2980 (C=C&#x02013;H), 1615 (C=N), 3500 (O&#x02013;H), 3320(N&#x02013;H). <sup>1</sup>HNMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; ppm: 3.91 (s, 3H, OCH<sub>3</sub>), 1.76 (d, 3H, CH<sub>3</sub>), 1.56&#x02013;1.57(d, J = 6.8 Hz), 4.48 (q, 1H, CH) 1.76&#x02013;1.79(<italic>J</italic> = 6.8), 7.70 (d, 1H, Ar), range (d, <italic>J</italic> = 6.2 Hz), 7.26 (d, 1H, Ar&#x02013;H), range (d, J = 6.0 Hz), 7.47 (s, 1H, Ar&#x02013;H), 7.57 (d, 1H, Ar&#x02013;H), range (d, J = 3.2), 7.04 (d, 1H, Ar&#x02013;H), range (d, <italic>J</italic> = 3.2 Hz), 7.07 (s, 1H, Ar&#x02013;H), 7.38 (d, 1H, Ar&#x02013;H), range (d, J = 2.0 Hz), 7.35 (d, 1H, Ar&#x02013;H), range (d, J = 2.0 Hz), 12.3 (s, 1H, NH), 7.67 (s, 1H, Ar&#x02013;H), 3.7 (s, 3H, OCH<sub>3</sub>); <sup>13</sup>CNMR, (75 MHz) &#x003b4; ppm: 70MHz (chiral carbon),141.5 (C=N imidazole), 156.2, 105.4 (Ar&#x02013;H), 130.3 (C&#x02013;Cl). HRMS (ESI): m/z calculated for C<sub>20</sub>H<sub>17</sub>ClN<sub>2</sub>O [M<sup>+</sup> + H<sup>+</sup>], 337.1108; found, 337.1109.</p></sec><sec id="sec2.3.8"><label>2.3.8</label><title>(&#x000b1;)-6-bromo-2-((R)-1-(2-methoxynaphthalen-6-yl)ethyl)-1H-benzo[d]imidazol (6c)</title><p id="p0090">(69%), m.p 202 &#x000b0;C; IR: <italic>&#x02c71;</italic>: 2976 (C=C&#x02013;H), 1614 (C=N), 3500 (O&#x02013;H), 3323(N&#x02013;H). <sup>1</sup>HNMR (400 MHz, DMSO) &#x003b4; ppm: 1.71 (d, 3H, CH<sub>3</sub>), 1.55&#x02013;1.56(d, J = 6.7 Hz), 3.90 (s, 3H, OCH<sub>3</sub>), 4.48 (q, 1H, CH) 1.75&#x02013;1.78(<italic>J</italic> = 6.7), 7.70 (d, 1H, Ar&#x02013;H), range (d, <italic>J</italic> = 6.2 Hz), 7.16 (d, 1H, Ar), range (d, J = 6.0 Hz), 7.32 (s, 1H, Ar), 7.35 (d, 1H, Ar), range (d, J = 3.2), 7.01 (d, 1H, Ar), range (d, <italic>J</italic> = 3.2 Hz), 7.01 (s, 1H, Ar), 7.29 (d, 1H, Ar), range (d, J = 2.0 Hz), 7.26 (d, 1H, Ar), range (d, J = 2.0 Hz), 12.3 (s, 1H, NH), 7.67 (s, 1H, Ar), 3.3 (s, 3H, OCH<sub>3</sub>); <sup>13</sup>CNMR, (75 MHz) &#x003b4; ppm: 70MHz (chiral carbon),140.1 (C=N imidazole), 153.2, 105.4 (Ar), 117.5 (C&#x02013;Br). HRMS (ESI): m/z calculated for C<sub>20</sub>H<sub>17</sub>BrN<sub>2</sub>O [M<sup>+</sup> + H<sup>+</sup>], 381.0603; found, 381.0605.</p></sec><sec id="sec2.3.9"><label>2.3.9</label><title>(&#x000b1;)-6-Nitro-2-((R)-1-(2-methoxynaphthalen-6-yl)ethyl)-1H-benzo[d]imidazol (6d)</title><p id="p0095">(69%), m.p 210 &#x000b0;C; IR: <italic>&#x02c71;</italic>: 2988 (C=C&#x02013;H), 1612 (C=N), 3500 (O&#x02013;H), 3331(N&#x02013;H). <sup>1</sup>HNMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; ppm: 3.91 (s, 3H, OCH<sub>3</sub>), 1.69 (d, 3H, CH<sub>3</sub>), 1.55&#x02013;1.56(d, J = 6.7 Hz), 4.38 (q, 1H, CH) 1.75&#x02013;1.78(<italic>J</italic> = 6.7), 7.70 (d, 1H, Ar), range (d, <italic>J</italic> = 6.2 Hz), 7.16 (d, 1H, Ar), range (d, J = 6.0 Hz), 7.32 (s, 1H, Ar), 7.35 (d, 1H, Ar), range (d, J = 3.2), 7.01 (d, 1H, Ar), range (d, <italic>J</italic> = 3.2 Hz), 7.01 (s, 1H, Ar), 7.29 (d, 1H, Ar), range (d, J = 2.0 Hz), 7.26 (d, 1H, Ar), range (d, J = 2.0 Hz), 12.3 (s, 1H, NH), 7.67 (s, 1H, Ar), 3.31 (s, 3H, OCH<sub>3</sub>); <sup>13</sup>CNMR, (75 MHz) &#x003b4; ppm: 70 (chiral carbon),141.1 MHz (C=N imidazole), 154.6, 105.4 (Ar), 144.5 (C&#x02013;NO<sub>2</sub>). HRMS (ESI): m/z calculated for C<sub>20</sub>H<sub>17</sub>N<sub>3</sub>O<sub>3</sub> [M<sup>+</sup> + Na<sup>+</sup>], 370.1168; found, 370.1165.</p></sec><sec id="sec2.3.10"><label>2.3.10</label><title>(&#x000b1;)-6-methyl-2-((R)-1-(2-methoxynaphthalen-6-yl)ethyl)-1H-benzo[d] imidazol (6e)</title><p id="p0100">(69%), m.p 212 &#x000b0;C; IR: <italic>&#x02c71;</italic>: 2988 (C=C&#x02013;H), 1612 (C=N), 3500 (O&#x02013;H), 3331(N&#x02013;H). <sup>1</sup>HNMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; ppm: 1.69 (d, 3H, CH<sub>3</sub>), 1.55&#x02013;1.56(d, <italic>J</italic> = 6.5 Hz), 3.91 (s, 3H, OCH<sub>3</sub>), 4.38 (q, 1H, CH) 1.75&#x02013;1.78(<italic>J</italic> = 6.6), 7.71 (d, 1H, Ar), range (d, <italic>J</italic> = 6.2 Hz), 7.16 (d, 1H, Ar), range (d, J = 6.1 Hz), 7.32 (s, 1H, Ar), 7.35 (d, 1H, Ar), range (d, J = 3.2), 7.01 (d, 1H, Ar), range (d, <italic>J</italic> = 3.2 Hz), 7.01 (s, 1H, Ar), 7.29 (d, 1H, Ar), range (d, J = 2.0 Hz), 7.26 (d, 1H, Ar), range (d, J = 2.0 Hz), 12.3 (s, 1H, NH), 7.67 (s, 1H, Ar), 3.31 (s, 3H, OCH<sub>3</sub>); <sup>13</sup>CNMR, (75 MHz) &#x003b4; ppm: 70 (chiral carbon),141.6 (C=N imidazole), 152.6, 105.4 (Ar), 22.6 (C&#x02013;CH<sub>3</sub>). HRMS (ESI): m/z calculated for C<sub>21</sub>H<sub>20</sub>N<sub>2</sub>O [M<sup>+</sup> + H<sup>+</sup>], 317.1654; found, 317.1650.</p></sec></sec></sec><sec id="sec3"><label>3</label><title>Results and discussions</title><p id="p0105">Numerous synthetic routes have been used for the preparation of benzimidazoles however our recent investigations involving hetrocyclization of orthophenylenediammine are very encouraging [<xref rid="bib25" ref-type="bibr">25a,b,c</xref>]. Thus in our initial attempt we have synthesized the chiral derivatives of benzimidazole by the hetrocyclization of orthophenylenediammine with lactic acid and secondly, evaluate their urease inhibition studies (see Tables <xref rid="tbl1" ref-type="table">1</xref> and <xref rid="tbl2" ref-type="table">2</xref>).<table-wrap position="float" id="tbl1"><label>Table&#x000a0;1</label><caption><p>Synthesis and urease inhibition studies of benzimidazoles derivatives <bold>3a-3f</bold>.</p></caption><alt-text id="alttext0065">Table&#x000a0;1</alt-text><table frame="hsides" rules="groups"><thead><tr><th colspan="4"><inline-graphic xlink:href="fx1.gif"><alt-text id="alttext0070">Image 1</alt-text></inline-graphic><hr/></th></tr><tr><th>compound</th><th>R</th><th>% yield</th><th>IC50 &#x000b1; SEM (&#x003bc;M)</th></tr></thead><tbody><tr><td>3a</td><td>H (R config.)</td><td>85</td><td>22 &#x000b1; 6.2</td></tr><tr><td>3b</td><td>Cl</td><td>80</td><td>38 &#x000b1; 18.2</td></tr><tr><td>3c</td><td>Br</td><td>82</td><td>46 &#x000b1; 8.3</td></tr><tr><td>3d</td><td>NO<sub>2</sub></td><td>78</td><td>66 &#x000b1; 27.4</td></tr><tr><td>3e</td><td>CH<sub>3</sub></td><td>86</td><td>36 &#x000b1; 9.2</td></tr><tr><td>3f</td><td>H (S-config.)</td><td>85</td><td>31 &#x000b1; 23.3</td></tr></tbody></table></table-wrap><table-wrap position="float" id="tbl2"><label>Table&#x000a0;2</label><caption><p>Synthesis and urease inhibition studies of benzimidazoles derivatives <bold>6a-6f</bold>.</p></caption><alt-text id="alttext0075">Table&#x000a0;2</alt-text><table frame="hsides" rules="groups"><thead><tr><th colspan="4"><inline-graphic xlink:href="fx2.gif"><alt-text id="alttext0080">Image 2</alt-text></inline-graphic><hr/></th></tr><tr><th>compound</th><th>R</th><th>% yield</th><th>IC50 &#x000b1; SEM (&#x003bc;M)</th></tr></thead><tbody><tr><td>6a</td><td>H (R config)</td><td>73</td><td>38 &#x000b1; 1.3</td></tr><tr><td>6b</td><td>Cl</td><td>70</td><td>36 &#x000b1; 1.7</td></tr><tr><td>6c</td><td>Br</td><td>69</td><td>51 &#x000b1; 9.3</td></tr><tr><td>6d</td><td>NO<sub>2</sub></td><td>69</td><td>99 &#x000b1; 9.4</td></tr><tr><td>6e</td><td>CH<sub>3</sub></td><td>69</td><td>44 &#x000b1; 2.4</td></tr><tr><td>6f</td><td>H (S-config.)</td><td>73</td><td>39 &#x000b1; 2.4</td></tr></tbody></table></table-wrap></p><p id="p0110">Chiral benzimidazoles were obtained in a yield range 70&#x02013;86%. The FT-IR spectrum displayed several characteristic bands round about 3305.08, 3152.47 2982.12, 2952.46, 1605, and 1145 cm<sup>&#x02212;1</sup>. More importantly the presence of characteristic peak C=N at 1605-1620 cm<sup>&#x02212;1</sup> has provided a strong evidence of formation imidazole ring of benzimidazole [<xref rid="bib26" ref-type="bibr">26a,b,c</xref>]. While the remaining observed vibration bands were assigned to (NH) stretching (3305.08), (Ar&#x02013;H) stretching vibrations (2982.12), (CH) stretching vibrations (2952.46), (C=N) stretching vibration (1605) and (OH) stretching vibration (3400cm<sup>&#x02212;1</sup>) [<xref rid="bib27" ref-type="bibr">27a,b,c</xref>].</p><p id="p0115">In the <sup>1</sup>H NMR and <sup>13</sup>CNMR we have found the characteristic peaks of benzimidazoles (Figure&#x000a0;S4 to S7 supporting information). The most downfield signal around 12.2 ppm for NH, methyl group at 1.51 ppm as a doublet due to &#x02018;AB&#x02019; spin system coupling with one neighboring proton, the peaks of aromatic ring ranging from 7.10-7.42 ppm. The molecular masses of the synthesized compounds were determined by their EIMS.</p><sec id="sec3.1"><label>3.1</label><title>DFT studies</title><sec id="sec3.1.1"><label>3.1.1</label><title>Geometry optimization</title><p id="p0120">Currently, computational methods attract a lot of attention to the study of the SAR of compounds, and DFT study is one of the most prominent calculation approach due to its accuracy and less time duration. The energy and geometries of <bold>3a-f</bold> (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>) and <bold>6a-f</bold> (Fig.&#x000a0;S1) were optimized at the B3LYP/6-31G (d, p) level of DFT by Gaussian 09 program [<xref rid="bib28" ref-type="bibr">28a,b,c</xref>]. In addition, investigation like MEP and FMOs carried out on optimized geometries [<xref rid="bib29" ref-type="bibr">29</xref>].<fig id="fig2"><label>Figure&#x000a0;2</label><caption><p>Optimized structures of compounds <bold>3a-f</bold> at B3LYP/6-31G (d, p); Atom color code: green, chlorine; red, oxygen; gray, carbon; brown, bromine blue, nitrogen; white, hydrogen.</p></caption><alt-text id="alttext0020">Figure&#x000a0;2</alt-text><graphic xlink:href="gr2"/></fig></p></sec><sec id="sec3.1.2"><label>3.1.2</label><title>Frontier molecular orbital (FMO) analysis</title><p id="p0125">This method is widely employed to explain the electronic as well as the optical properties of compounds. The main participants during molecular interactions, are the highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital (LUMO). These values used to determine the kinetic stability and chemical reactivity of molecules. The energy of LUMO energy level represents electron-accepting abilities while HOMO shows electron donating ability.</p><p id="p0130">We depict the HOMO-LUMO energy diagram (Fig.&#x000a0;S2 and Fig.&#x000a0;S3) show that electron rich region (red), electron scale region (green). The populations analysis revealed that iso-densities are mainly concentrated on imidazole and aromatic moieties. The HOMO-LUMO energy gaps are summarized in <xref rid="tbl3" ref-type="table">Table&#x000a0;3</xref>. This energy gap for <bold>3a, 3f</bold> is found to be the maximum and equal to 5.61 eV, while the least band gap (4.48 eV and 3.71 eV,) was determined for <bold>3d, 6d</bold>. The iso-density in HOMO of <bold>3a, 3f</bold> is mainly spread only to the rings, which reflects less conjugation. This observation indicates that the HOMO-LUMO gap in <bold>3a, 3f</bold> should display the highest energy among all products studied, and indeed this was the case.<table-wrap position="float" id="tbl3"><label>Table&#x000a0;3</label><caption><p>HOMO and LUMO energies along with HOMO-LUMO energy gap of products <bold>3a-f</bold> and <bold>6a-f</bold>.</p></caption><alt-text id="alttext0085">Table&#x000a0;3</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Entry</th><th>HOMO (a.u)</th><th>LUMO (a.u)</th><th>HOMO/LUMO (<italic>&#x00394;E/Ev)</italic></th></tr></thead><tbody><tr><td>3a</td><td>-0.21439</td><td>-0.00815</td><td>5.61</td></tr><tr><td>3b</td><td>-0.21869</td><td>-0.02077</td><td>5.38</td></tr><tr><td>3c</td><td>-0.21706</td><td>-0.02119</td><td>5.33</td></tr><tr><td>3d</td><td>-0.24394</td><td>-0.07919</td><td>4.48</td></tr><tr><td>3e</td><td>-0.20726</td><td>-0.00459</td><td>5.51</td></tr><tr><td>3f</td><td>-0.21438</td><td>-0.00814</td><td>5.61</td></tr><tr><td>6a</td><td>-0.20685</td><td>-0.04243</td><td>4.47</td></tr><tr><td>6b</td><td>-0.20979</td><td>-0.04580</td><td>4.55</td></tr><tr><td>6c</td><td>-0.20984</td><td>-0.04580</td><td>4.46</td></tr><tr><td>6d</td><td>-0.21473</td><td>-0.07855</td><td>3.71</td></tr><tr><td>6e</td><td>-0.20505</td><td>-0.04174</td><td>4.44</td></tr><tr><td>6f</td><td>-0.20663</td><td>-0.04241</td><td>4.47</td></tr></tbody></table></table-wrap></p><p id="p0135">In <bold>3e</bold>, the density on the HOMO spread over the entire scaffold (including the CH<sub>3</sub> substituent) in the same region as compared to <bold>3a, 3f</bold>; therefore, its energy gap is comparable to that of <bold>3a, 3f</bold> (i.e., of 5.51 eV). This slightly smaller energy gap in <bold>3e</bold> is expected due to the presence of planarity and the electron donating-effect of the methyl group (see <xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>).<fig id="fig3"><label>Figure&#x000a0;3</label><caption><p>Frontier molecular orbitals (HOMO-LUMO) of compounds <bold>3a-f</bold> at B3LYP/6-31G (d, p) base set level. (FMO for <bold>6a-f</bold> are included in figure S2).</p></caption><alt-text id="alttext0025">Figure&#x000a0;3</alt-text><graphic xlink:href="gr3"/></fig></p></sec><sec id="sec3.1.3"><label>3.1.3</label><title>Molecular electrostatic potential (MEP)</title><p id="p0140"><disp-formula id="fd1"><label>(1)</label><mml:math id="M1" altimg="si1.svg" alttext="Equation 1."><mml:mrow><mml:mi>V</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>r</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo linebreak="badbreak">=</mml:mo><mml:mo>&#x02211;</mml:mo><mml:mfrac><mml:msub><mml:mi>Z</mml:mi><mml:mi>A</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">|</mml:mo><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>A</mml:mi></mml:msub><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mo stretchy="true">|</mml:mo></mml:mrow></mml:mfrac><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:mrow><mml:mo>&#x0222b;</mml:mo><mml:mfrac><mml:mrow><mml:mi>&#x003c1;</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:msup><mml:mi>r</mml:mi><mml:mo>&#x02032;</mml:mo></mml:msup><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mo stretchy="true">|</mml:mo><mml:mrow><mml:msup><mml:mi>r</mml:mi><mml:mo>&#x02032;</mml:mo></mml:msup><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mo stretchy="true">|</mml:mo></mml:mrow></mml:mfrac></mml:mrow><mml:mi>d</mml:mi><mml:msup><mml:mi>r</mml:mi><mml:mo>&#x02032;</mml:mo></mml:msup></mml:mrow></mml:math></disp-formula></p><p id="p0145">Z<sub>A</sub> is the nuclear charge present at a distance R<sub>A</sub> and &#x003c1;(r') representing electron density. The molecular electrostatic potential (MEP) mapping utilize DFT techniques can be beneficial in biochemistry to decide drug-receptor interactions. The MEP is associated chemically active sites of a molecule and additionally improves the perception of molecular reactivity, electrophilic reactions, substituent effects, inter and intra-molecular relations. The increasing electrostatic potential in the following order: red, yellow, blue and green. According to color scale, electron rich (red), slightly electron rich (yellow) which is due to the lone pair of oxygen atom, electron deficient (blue) region of the molecule was surrounded over the hydrogen atoms. Which is due to the electronegative nitrogen atom being attached with the hydrogen atoms. The neutral electrostatic potential (green) envelopes over the &#x003c0;-system of the ring. The electrophilic region of the molecule was predicted around the hydrogen atoms of benzene and imidazole ring. The reactive sites of electrophilic and nucleophilic attacks are investigated for all products <bold>3a~f, 6a~f</bold> was computed by MEP the use of B3LYP/6-31G (d, p) at 0.02 a.u is values for the Map surface are proven in <xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref> and Fig S3. MEP analysis revealed that the negative potential is concentrated on the N atoms on the imidazole rings (<bold>3a~f, 6a~f</bold>) and oxygen atoms of the NO<sub>2</sub> (3d, 6d) moiety (attached to the benzene ring) and as a result this is the preferred site for electrophilic attack, In addition, the positive charge regions are located on the H atoms on the imidazole (NH group) ring. The negative (-ve) and positive (+ve) potential values of each compound are listed in <xref rid="tbl4" ref-type="table">Table&#x000a0;4</xref>.<fig id="fig4"><label>Figure&#x000a0;4</label><caption><p>Calculated MEP maps of compounds <bold>3a-f</bold> at B3LYP/6-31G (d,p). (MEP maps of compounds <bold>6a-f</bold> is in figure S3).</p></caption><alt-text id="alttext0030">Figure&#x000a0;4</alt-text><graphic xlink:href="gr4"/></fig><table-wrap position="float" id="tbl4"><label>Table&#x000a0;4</label><caption><p>Values of -ve and +ve potential of products <bold>3a&#x02013;f, 6a-f</bold> computed at the DFT/B3LYP/6-31G (d,p) level.</p></caption><alt-text id="alttext0090">Table&#x000a0;4</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Entry</th><th>Compound</th><th>Negative potential (a.u)</th><th>Positive potential (a.u)</th></tr></thead><tbody><tr><td>1</td><td>3a</td><td>-0.06386</td><td>0.06386</td></tr><tr><td>2</td><td>3b</td><td>-0.06747</td><td>0.06747</td></tr><tr><td>3</td><td>3c</td><td>-0.06808</td><td>0.06808</td></tr><tr><td>4</td><td>3d</td><td>-0.07353</td><td>0.07353</td></tr><tr><td>5</td><td>3e</td><td>-0.06284</td><td>0.06284</td></tr><tr><td>6</td><td>3f</td><td>-0.06346</td><td>0.06346</td></tr><tr><td>7</td><td>6a</td><td>-0.05524</td><td>0.05524</td></tr><tr><td>8</td><td>6b</td><td>-0.05396</td><td>0.05396</td></tr><tr><td>9</td><td>6c</td><td>-0.05360</td><td>0.05360</td></tr><tr><td>10</td><td>6d</td><td>-0.05997</td><td>0.05997</td></tr><tr><td>11</td><td>6e</td><td>-0.05647</td><td>0.05647</td></tr><tr><td>12</td><td>6f</td><td>-0.05765</td><td>0.05765</td></tr></tbody></table></table-wrap></p><p id="p0150">From the results in <xref rid="tbl4" ref-type="table">Table&#x000a0;4</xref>, it is clear that both potential of all testing compounds are seen as about in a similar range and no noteworthy distinction was seen. The minimal value was observed for <bold>6c</bold> (-0.05360 a.u. to 0.05360 a.u), whereas the highest value was observed for <bold>3d</bold> (-0.07353 a.u. to 0.07353 a.u).</p></sec></sec><sec id="sec3.2"><label>3.2</label><title>Jack bean urease inhibition study</title><p id="p0155">The current work accounts the study of several chiral benzimidazole derivatives (<bold>3a~f</bold> and <bold>6a~f</bold>) as inhibitors of jack bean ureases. All of the benzimidazoles showed variety of urease inhibitory orders.</p><p id="p0160">As the above experimental values of compounds <bold>3a, 3b</bold> and <bold>3f</bold> revealed that they exhibited good enzyme inhibitory activity with IC<sub>50</sub> 0.064 and 0.058l M respectively, while benzimidazoles containing no withdrawing groups on benzene ring are quite effective. The compound <bold>3a</bold> (22.26 &#x000b1; 6.2) acted as good urease inhibitor while the experimental values of <bold>3d</bold> (99 &#x000b1; 19.4) indicates that the withdrawing moiety (NO<sub>2</sub>) on benzimidazole decreases its urease inhibition activity while IC<sub>50</sub> of reference thiourea is 20.92 M. Another key thing to remember was the structure of acid used in <xref rid="sch1" ref-type="fig">Scheme 1</xref>. The smaller acid moiety (Lactic acid) containing benzimidazoles (<bold>3a~f</bold>) were more effective than the one having bulky acid naproxen (<bold>6a~f</bold>).<fig id="sch1"><label>Scheme 1</label><caption><p>General scheme for the synthesis of chiral derivatives of benzimidazoles.</p></caption><alt-text id="alttext0060">Scheme 1</alt-text><graphic xlink:href="sc1"/></fig></p><p id="p0165">Imidazole ring has central importance in urease inhibition thus any substitution on side phenyl ring of imidazole can affect the urease inhibition activity of benzimidazole. Based on our research we propose that the chiral benzimidazole 3a, 3b and 3f can serve as good competitive inhibitors.</p></sec><sec id="sec3.3"><label>3.3</label><title>Molecular docking studies of chiral benzimidazole with urease enzyme (3LA4)</title><p id="p0170">The compounds <bold>3a</bold> and <bold>6d</bold> along with reference compound thiourea were studied by using docking AutoDock Tools v1.5.6 for protein-ligand docking the virtual screening tool via VINA module. Results are obtained in the form of binding affinity (kcal/mol) which shows the strength of binding interactions between ligand and receptor (<xref rid="tbl5" ref-type="table">Table&#x000a0;5</xref>).<table-wrap position="float" id="tbl5"><label>Table&#x000a0;5</label><caption><p>Binding affinity of ligands with receptor urease enzyme.</p></caption><alt-text id="alttext0095">Table&#x000a0;5</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Sr.No.</th><th>Ligands</th><th>Binding Affinity<break/>Kcal/mol</th></tr></thead><tbody><tr><td>1</td><td><bold>3a</bold> +3LA4</td><td>-4.8</td></tr><tr><td>2</td><td><bold>6d</bold> +3LA4</td><td>-8.6</td></tr><tr><td>3</td><td>Tiourea+3LA4 (standard)</td><td>-3.3</td></tr></tbody></table></table-wrap></p><p id="p0175">As we observed that the order of in-silico and in-vitro results comply with each other. The compound <bold>3a</bold> which is the most potent among our synthesized compounds has shown better binding energy (-4.8 Kcal/mol) as compared to least potent compound <bold>6d</bold> (-8.6 Kcal/mol) (Figure&#x000a0;S8). Docking studies revealed that, Hydrogen bond formations were considered as most important for perfect firm fitting of ligand within the active site of enzyme [<xref rid="bib30" ref-type="bibr">30</xref>]. In the binding model of the most potent compound <bold>3a,</bold> three hydrogen bonds were noticed between residues GLU742, LEU13 and PRO74 with hydroxyl and N&#x02013;H groups of ligands (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>).<fig id="fig5"><label>Figure&#x000a0;5</label><caption><p>Protein-ligand Interaction between chiral benzimdazole <bold>3a</bold> and active residue of enzyme (3LA4) where <inline-graphic xlink:href="fx3.gif"><alt-text id="alttext0035">Image 3</alt-text></inline-graphic> Vander Waal forces, <inline-graphic xlink:href="fx4.gif"><alt-text id="alttext0040">Image 4</alt-text></inline-graphic>hydrogen bonding<inline-graphic xlink:href="fx5.gif"><alt-text id="alttext0045">Image 5</alt-text></inline-graphic>unfavorable doner-doner and <inline-graphic xlink:href="fx6.gif"><alt-text id="alttext0050">Image 6</alt-text></inline-graphic>pi alkyl. (Docking for reference thiourea is attached in Figure&#x000a0;S9).</p></caption><alt-text id="alttext0055">Figure&#x000a0;5</alt-text><graphic xlink:href="gr5"/></fig></p></sec></sec><sec id="sec4"><label>4</label><title>Conclusion</title><p id="p0180">Chiral derivatives of benzimidazoles have been synthesized to validate their role in jack bean urease inhibition. All of the above synthesized compounds showed significant inhibition. The compound <bold>3a, 3b</bold> and <bold>3f</bold> were found to be most potent among all above synthesized compounds. Computational studies also enabled us to understand the electronic effects on different substituted chiral benzimidazole. The most responsive sites for nucleophilic and electrophilic attack were predicted by the MEP analysis. On the other hand, FMOs analysis shows that the molecule energy gap for <bold>3a, 3f</bold> is found to be the maximum and equal to 5.61 eV, which influences the biological activity of the compound. While the least band gap (4.48 eV and 3.71 eV,) was determined for <bold>3d, 6d</bold> were not showing significant urease inhibition, because of its low kinetic stability and high chemical reactivity. In addition, docking studies were performed to elaborate the interaction of ligands with residues of active enzyme which was consistent with experimental results. During this study we have found the effect of chirality on urease inhibition whereas the detailed impact of chirality and synthesis of molecules after docking studies is a project underway.</p></sec><sec id="sec5"><title>Declarations</title><sec id="sec5.1"><title>Author contribution statement</title><p id="p0185">Naghmana Rashid: Conceived and designed the experiments; Contributed reagents, materials, analysis tools or data.</p><p id="p0190">Hasil Aman: Conceived and designed the experiments; Performed the experiments; Contributed reagents, materials, analysis tools or data; Wrote the paper.</p><p id="p0195">Mohammad Zaman Ashraf: Conceived and designed the experiments; Analyzed and interpreted the data; Wrote the paper.</p><p id="p0200">Nadaraj Sathishkumar: Analyzed and interpreted the data.</p><p id="p0205">Hsin-Tsung Chen: Analyzed and interpreted the data; Wrote the paper.</p><p id="p0210">Aamna Bibi: Contributed reagents, materials, analysis tools or data.</p></sec><sec id="sec5.2"><title>Funding statement</title><p id="p0215">This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</p></sec><sec id="sec5.3"><title>Competing interest statement</title><p id="p0220">The authors declare no conflict of interest.</p></sec><sec id="sec5.4"><title>Additional information</title><p id="p0225">No additional information is available for this paper.</p></sec></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Bansal</surname><given-names>Y.</given-names></name><name><surname>Silakari</surname><given-names>O.M.</given-names></name></person-group><article-title>The therapeutic journey of benzimidazoles: a review</article-title><source>Bioorg. Med. Chem.</source><volume>20</volume><year>2012</year><fpage>6208</fpage><lpage>6236</lpage><pub-id pub-id-type="pmid">23031649</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Demirci</surname><given-names>S.</given-names></name><name><surname>Basoglu</surname><given-names>S.</given-names></name><name><surname>Bozdereci</surname><given-names>A.</given-names></name><name><surname>Demirbas</surname><given-names>N.</given-names></name></person-group><article-title>Preparation and antimicrobial activity evaluation of some new bi- and tri-heterocyclic azoles</article-title><source>Med. Chem. Res.</source><volume>22</volume><year>2013</year><fpage>4939</fpage><lpage>4945</lpage></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Thamban</surname><given-names>N.</given-names></name><name><surname>Sanjib</surname><given-names>K.</given-names></name><name><surname>Ranjan</surname><given-names>N.</given-names></name><name><surname>Sharma</surname><given-names>A.</given-names></name><name><surname>Arya</surname><given-names>D.P.</given-names></name><name><surname>Garneau-Tsodikova</surname><given-names>S.</given-names></name></person-group><article-title>New application of neomycin B&#x02212;Bisbenzimidazole hybrids as antifungal agents</article-title><source>ACS Infect. Dis.</source><volume>4</volume><year>2018</year><fpage>196</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">29227087</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Eevic</surname><given-names>K.S.</given-names></name><name><surname>Kralj</surname><given-names>M.</given-names></name><name><surname>Ester</surname><given-names>K.</given-names></name><name><surname>Sabol</surname><given-names>I.</given-names></name><name><surname>Grce</surname><given-names>M.</given-names></name><name><surname>Pavelic</surname><given-names>K.I.</given-names></name><name><surname>Zamola</surname><given-names>G.K.</given-names></name></person-group><article-title>Synthesis, antiviral and antitumor activity of 2-substituted-5-amidino-benzimidazoles</article-title><source>Bioorg. Med. Chem.</source><volume>15</volume><year>2007</year><fpage>4419</fpage><lpage>4426</lpage><pub-id pub-id-type="pmid">17482821</pub-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="bib5a"><label>(a)</label><person-group person-group-type="author"><name><surname>Ito</surname><given-names>Y.</given-names></name><name><surname>Shibata</surname><given-names>K.</given-names></name><name><surname>Hongo</surname><given-names>A.</given-names></name><name><surname>Kinoshita</surname><given-names>M.</given-names></name></person-group><article-title>Ecabetsodium, a locally acting antiulcer drug, inhibitsurease activity of Helicobacter pylori</article-title><source>Eur. J. Pharmacol.</source><volume>345</volume><year>1998</year><fpage>193</fpage><lpage>198</lpage><pub-id pub-id-type="pmid">9600637</pub-id></element-citation><element-citation publication-type="journal" id="bib5b"><label>(b)</label><person-group person-group-type="author"><name><surname>Gellis</surname><given-names>A.</given-names></name><name><surname>Kovacic</surname><given-names>H.</given-names></name><name><surname>Boufatah</surname><given-names>N.</given-names></name><name><surname>Vanelle</surname><given-names>P.</given-names></name></person-group><article-title>Synthesis and cytotoxicity evaluation of some benzimidazole-4, 7-diones as bioreductive anticancer agents</article-title><source>Eur. J. Med. Chem.</source><volume>43</volume><year>2008</year><fpage>1858</fpage><lpage>1864</lpage><pub-id pub-id-type="pmid">18222567</pub-id></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Sethi</surname><given-names>P.</given-names></name><name><surname>Bansal</surname><given-names>Y.</given-names></name><name><surname>Bansal</surname><given-names>G.</given-names></name></person-group><article-title>Synthesis and PASS-assisted evaluation of coumarin&#x02013;benzimidazole derivatives as potential anti-inflammatory and anthelmintic agents</article-title><source>Med. Chem. Res.</source><volume>27</volume><year>2017</year><fpage>61</fpage></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Boiani</surname><given-names>M.</given-names></name><name><surname>Gonzalez</surname><given-names>M.</given-names></name></person-group><article-title>Imidazole and benzimidazole derivatives as chemotherapeutic agents</article-title><source>Eur. J. Med. Chem.</source><volume>5</volume><year>2005</year><fpage>409</fpage><lpage>424</lpage></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Jin-Feng</surname><given-names>X.</given-names></name><name><surname>Jian</surname><given-names>X.L.</given-names></name><name><surname>Guang</surname><given-names>ZMo</given-names></name><name><surname>Jing</surname><given-names>P.H.</given-names></name><name><surname>Jin</surname><given-names>Y.L.</given-names></name><name><surname>Xiao</surname><given-names>Y.C.</given-names></name><name><surname>Zhao</surname><given-names>Y.W.</given-names></name></person-group><article-title>Benzimidazole derivatives selective fluorescent chemo-sensors for the pictogram detection of picric acid</article-title><source>J.&#x000a0;Org. Chem.</source><volume>79</volume><issue>23</issue><year>2014</year><fpage>11619</fpage><lpage>11630</lpage><pub-id pub-id-type="pmid">25387225</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Atar</surname><given-names>A.</given-names></name><name><surname>Taspinar</surname><given-names>&#x000d6;.</given-names></name><name><surname>Hanft</surname><given-names>S.</given-names></name><name><surname>Goldfuss</surname><given-names>B.</given-names></name><name><surname>Schmalz</surname><given-names>H.G.</given-names></name><name><surname>Griesbeck</surname><given-names>A.G.</given-names></name></person-group><article-title>Hydrogen peroxide sensors based on fluorescence quenching of the 2-aminobenzimidazole fluorophore</article-title><source>J.&#x000a0;Org. Chem.</source><volume>84</volume><year>2019</year><fpage>15972</fpage><lpage>15977</lpage><pub-id pub-id-type="pmid">31769288</pub-id></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Gautam</surname><given-names>R.D.</given-names></name></person-group><article-title>Supramolecular synthons in crystal engineering a new organic synthesis</article-title><source>Angewandte chemie Intenational Edition in English</source><volume>34</volume><year>1995</year><fpage>2311</fpage><lpage>2327</lpage></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="bib11a"><label>(a)</label><person-group person-group-type="author"><name><surname>Curkovic</surname><given-names>H.O.</given-names></name><name><surname>Stupnisek-Lisac</surname><given-names>E.</given-names></name><name><surname>Takenouti</surname><given-names>H.</given-names></name></person-group><article-title>The influence of pH value on the efficiency of imidazole based corrosion inhibitors of copper</article-title><source>Corrossion Sci.</source><volume>52</volume><year>2010</year><fpage>398</fpage><lpage>405</lpage></element-citation><element-citation publication-type="journal" id="bib11b"><label>(b)</label><person-group person-group-type="author"><name><surname>Madkour</surname><given-names>L.H.</given-names></name><name><surname>Elshamy</surname><given-names>I.H.</given-names></name></person-group><article-title>Experimental and computational studies on the inhibition performances of benzimidazole and its derivatives for the corrosion of copper in nitric acid</article-title><source>Int. J. Integrated Care</source><volume>7</volume><year>2016</year><fpage>195</fpage><lpage>221</lpage></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Benavent</surname><given-names>L.</given-names></name><name><surname>Baeza</surname><given-names>A.</given-names></name><name><surname>Freckleton</surname><given-names>M.</given-names></name></person-group><article-title>Chiral 2-aminobenzimidazole as bifunctional catalyst in the asymmetric electrophilic amination of unprotected 3-substituted oxindoles</article-title><source>Molecules</source><volume>23</volume><year>2018</year><fpage>1374</fpage></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="bib13a"><label>(a)</label><person-group person-group-type="author"><name><surname>Arjmand</surname><given-names>F.</given-names></name><name><surname>Parveen</surname><given-names>S.</given-names></name><name><surname>Afzal</surname><given-names>M.</given-names></name><name><surname>Shahid</surname><given-names>M.</given-names></name></person-group><article-title>Synthesis, characterization, biological studies (DNA binding, cleavage, antibacterial and topoisomerase(I) and molecular docking of copper(II)benzimidazole complexes</article-title><source>J.&#x000a0;Photochem.</source><volume>114</volume><year>2012</year><fpage>15</fpage><lpage>26</lpage></element-citation><element-citation publication-type="journal" id="bib13b"><label>(b)</label><person-group person-group-type="author"><name><surname>Lopez-Rodr&#x00131;guez</surname><given-names>M.L.</given-names></name><name><surname>Benhamu</surname><given-names>B.</given-names></name><name><surname>Morcillo</surname><given-names>M.J.</given-names></name><name><surname>Tejada</surname><given-names>I.D.</given-names></name><name><surname>Orensanz</surname><given-names>L.</given-names></name><name><surname>Alfaro</surname><given-names>M.J.</given-names></name><name><surname>Mart&#x00131;n</surname><given-names>M.I.</given-names></name></person-group><article-title>Benzimidazole derivatives. 2. Synthesis and structure-activity relationships of new azabicyclic benzimidazole-4-carboxylic acid derivatives with affinity for serotoninergic 5-HT3 receptors</article-title><source>J.&#x000a0;Med. Chem.</source><volume>42</volume><year>1999</year><fpage>5020</fpage><lpage>5028</lpage><pub-id pub-id-type="pmid">10585211</pub-id></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Khalid</surname><given-names>M.W.</given-names></name><name><surname>Ismail</surname><given-names>H.</given-names></name><name><surname>Bushra</surname><given-names>M.</given-names></name><name><surname>Brendan</surname><given-names>T.</given-names></name><name><surname>Zareen</surname><given-names>A.</given-names></name><name><surname>Rozas</surname><given-names>I.</given-names></name><name><surname>Baker</surname><given-names>R.J.</given-names></name></person-group><article-title>Synthesis, DNA binding and antibacterial activity of metal(II) complexes of a benzimidazole Schiff base</article-title><source>Polyhedron</source><volume>157</volume><year>2019</year><fpage>326</fpage><lpage>334</lpage></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="bib15a"><label>(a)</label><person-group person-group-type="author"><name><surname>Kot</surname><given-names>M.</given-names></name><name><surname>Karcz</surname><given-names>W.</given-names></name><name><surname>Zaborska</surname><given-names>W.</given-names></name></person-group><article-title>5-Hydroxy-1, 4-naphthoquinone (juglone) and 2-hydroxy-1,4-naphthoquinone (lawsone) influence on jack bean ureaseactivity: elucidation of the difference in inhibition activity</article-title><source>Bioorg. Med. Chem.</source><volume>38</volume><year>2010</year><fpage>132</fpage><lpage>137</lpage></element-citation><element-citation publication-type="journal" id="bib15b"><label>(b)</label><person-group person-group-type="author"><name><surname>Amtul</surname><given-names>A.</given-names></name><name><surname>Rahman</surname><given-names>A.</given-names></name><name><surname>Siddiqui</surname><given-names>R.A.</given-names></name><name><surname>Choudhary</surname><given-names>M.I.</given-names></name></person-group><article-title>Chemistry and mechanism of urease inhibition</article-title><source>Curr. Med. Chem.</source><volume>9</volume><year>2002</year><fpage>14</fpage></element-citation><element-citation publication-type="journal" id="bib15c"><label>(c)</label><person-group person-group-type="author"><name><surname>Saeed</surname><given-names>A.</given-names></name><name><surname>Mahmood</surname><given-names>S.</given-names></name><name><surname>Ashraf</surname><given-names>Z.</given-names></name><name><surname>Jabeen</surname><given-names>F.</given-names></name></person-group><article-title>Iminothiazoline-sulfonamide hybrids as jack bean urease inhibitors; synthesis, kinetic mechanism and computational molecular modeling</article-title><source>Chem. Biol. Drug Des.</source><volume>87</volume><year>2016</year><fpage>434</fpage><lpage>443</lpage><pub-id pub-id-type="pmid">26496515</pub-id></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Modolo</surname><given-names>Luzia V.</given-names></name><name><surname>da-Silva</surname><given-names>Cristiane J.</given-names></name><name><surname>Brand&#x000e3;o</surname><given-names>D&#x000e9;bora S.</given-names></name><name><surname>Chaves</surname><given-names>Izabel S.</given-names></name></person-group><article-title>A&#x000a0;mini review on what we have learned about urease inhibitors of agricultural interest since mid-2000s</article-title><source>J.&#x000a0;Adv. Res.</source><volume>13</volume><year>2018</year><fpage>29</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">30094080</pub-id></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="bib17a"><label>(a)</label><person-group person-group-type="author"><name><surname>Sigurdarson</surname><given-names>J.J.</given-names></name><name><surname>Svane</surname><given-names>S.</given-names></name><name><surname>Karring</surname><given-names>H.</given-names></name></person-group><article-title>The molecular processes of urea hydrolysis in relation to ammonia emissions from agriculture</article-title><source>Rev. Environ. Sci. Biotechnol./Technol.</source><volume>17</volume><year>2018</year><fpage>241</fpage><lpage>258</lpage></element-citation><element-citation publication-type="journal" id="bib17b"><label>(b)</label><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>He</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Zhao</surname><given-names>W.</given-names></name><name><surname>Sun</surname><given-names>S.</given-names></name><name><surname>Zhao</surname><given-names>C.</given-names></name></person-group><article-title>Safe and effective removal of urea by urease-immobilized, carboxyl-functionalized PES beads with good reusability and storage stability</article-title><source>ACS Omega</source><volume>4</volume><year>2019</year><fpage>2853</fpage><lpage>2862</lpage></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Prywer</surname><given-names>J.</given-names></name><name><surname>Olszynski</surname><given-names>M.</given-names></name><name><surname>Brzoska</surname><given-names>E.M.</given-names></name></person-group><article-title>Green tea and struvite crystals in relation to infectious urinary stones: the role of (&#x02212;)-Epicatechin</article-title><source>Cryst. Growth Des.</source><volume>17</volume><year>2017</year><fpage>5953</fpage><lpage>5964</lpage></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="book" id="bib19a"><label>(a)</label><person-group person-group-type="author"><name><surname>Francis</surname><given-names>C.A.</given-names></name><name><surname>Roberts</surname><given-names>K.J.</given-names></name><name><surname>Beman</surname><given-names>J.M.</given-names></name><name><surname>Santoro</surname><given-names>A.E.</given-names></name><name><surname>Oakley</surname><given-names>B.B.</given-names></name></person-group><chapter-title>Ubiquity and diversity of ammonia-oxidizing archaea in water columns and sediments of the ocean</chapter-title><source>Proceedings of the Natural Academy of Sciences</source><year>2005</year><fpage>14683</fpage><lpage>14688</lpage></element-citation><element-citation publication-type="journal" id="bib19b"><label>(b)</label><person-group person-group-type="author"><name><surname>Zaman</surname><given-names>M.</given-names></name><name><surname>Nguyen</surname><given-names>M.L.</given-names></name><name><surname>Blennerhassett</surname><given-names>J.D.</given-names></name><name><surname>Quin</surname><given-names>B.F.</given-names></name></person-group><article-title>Reducing NH<sub>3</sub>, N<sub>2</sub>O and NO<sub>3</sub><sup>-</sup> losses from a pasture soil with urease or nitrification inhibitors and elemental S-amended nitrogenous fertilizers</article-title><source>Biol. Fertil. Soils</source><volume>44</volume><year>2008</year><fpage>693</fpage><lpage>705</lpage></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Mazzei</surname><given-names>L.</given-names></name><name><surname>Cianci</surname><given-names>M.</given-names></name><name><surname>Benini</surname><given-names>S.</given-names></name><name><surname>Ciurli</surname><given-names>S.</given-names></name></person-group><article-title>The structure of the elusive urease&#x02013;urea complex unveils the mechanism of a paradigmatic nickel-dependent enzyme</article-title><source>Angew. Chem. Int. Ed.</source><volume>58</volume><year>2019</year><fpage>7415</fpage><lpage>7419</lpage></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Kafarski</surname><given-names>P.</given-names></name><name><surname>Talma</surname><given-names>Micha&#x00142;</given-names></name></person-group><article-title>Recent advances in design of new urease inhibitors: a review</article-title><source>J.&#x000a0;Adv. Res.</source><volume>13</volume><year>2018</year><fpage>101</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">30094085</pub-id></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Al-Sehemi</surname><given-names>A.G.M.</given-names></name><name><surname>El-Sharief</surname><given-names>A.</given-names></name><name><surname>Ammar</surname><given-names>Y.A.</given-names></name></person-group><article-title>Propionic acids in organic synthesis: novel synthesis of benzimidazole, 3,1-benzoxazine, 3-aminoquinazoline and 3-aminothieno[2,3-d]pyrimidine derivatives containing 2-naphthyl propionyl moiety</article-title><source>Indian J. Chem.</source><volume>45</volume><year>2006</year><fpage>450</fpage><lpage>455</lpage></element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Tai</surname><given-names>K.T.</given-names></name><name><surname>Yen</surname><given-names>J.H.</given-names></name></person-group><article-title>Separation, bioactivity, and dissipation of enantiomers of the organophosphorus insecticide fenamiphos</article-title><source>Ecotoxicol. Environ. Saf.</source><volume>57</volume><year>2004</year><fpage>346</fpage><lpage>353</lpage><pub-id pub-id-type="pmid">15041257</pub-id></element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Saeed</surname><given-names>A.</given-names></name><name><surname>Mahmood</surname><given-names>S.</given-names></name><name><surname>Rafiq</surname><given-names>M.</given-names></name><name><surname>Ashraf</surname><given-names>Z.</given-names></name><name><surname>Jabeen</surname><given-names>F.</given-names></name><name><surname>Seo</surname><given-names>S.Y.</given-names></name></person-group><article-title>Iminothiazoline-sulfonamide hybrids as jack bean urease inhibitors; synthesis, kinetic mechanism and computational molecular modeling</article-title><source>Chem. Biol. Drug De</source><volume>87</volume><year>2016</year><fpage>434</fpage><lpage>443</lpage></element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="journal" id="bib25a"><label>(a)</label><person-group person-group-type="author"><name><surname>Menon</surname><given-names>V.V.</given-names></name><name><surname>Foto</surname><given-names>E.</given-names></name><name><surname>Mary S</surname><given-names>Y.</given-names></name><name><surname>Karatas</surname><given-names>E.</given-names></name><name><surname>Panicker</surname><given-names>C.Y.</given-names></name><name><surname>Yalcin</surname><given-names>G.</given-names></name><name><surname>Armakovi</surname><given-names>S.</given-names></name><name><surname>Sanja</surname><given-names>J.</given-names></name><name><surname>Armakovi</surname><given-names>C.</given-names></name><name><surname>Alsenoy</surname><given-names>V.</given-names></name><name><surname>Yildiz</surname><given-names>V.I.</given-names></name></person-group><article-title>Vibrational spectroscopic analysis, molecular dynamics simulations and molecular docking study of 5-nitro-2-phenoxymethyl benzimidazole</article-title><source>J.&#x000a0;Mol. Struct.</source><volume>1129</volume><year>2017</year><fpage>86</fpage><lpage>97</lpage></element-citation><element-citation publication-type="journal" id="bib25b"><label>(b)</label><person-group person-group-type="author"><name><surname>Dudd</surname><given-names>L.M.</given-names></name><name><surname>Venardou</surname><given-names>E.V.</given-names></name><name><surname>Garcia-Verdugo</surname><given-names>E.</given-names></name><name><surname>Licence</surname><given-names>P.</given-names></name><name><surname>Blake</surname><given-names>A.J.</given-names></name><name><surname>Wilson</surname><given-names>C.</given-names></name><name><surname>Poliakoff</surname><given-names>M.</given-names></name></person-group><article-title>Synthesis of benzimidazole in high temperature water</article-title><source>Green Chem.</source><volume>5</volume><year>2003</year><fpage>187</fpage><lpage>192</lpage></element-citation><element-citation publication-type="journal" id="bib25c"><label>(c)</label><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>A.</given-names></name><name><surname>Mohammed</surname><given-names>H.</given-names></name><name><surname>Anil</surname><given-names>K.A.</given-names></name></person-group><article-title>Chiral benzimidazole-derived mono aza-crowns: synthesis and enantiomer recognition studies with chiral amines and their ammonium salts</article-title><source>Tetrahedron-Asymmeter</source><volume>24</volume><year>2013</year><fpage>706</fpage><lpage>712</lpage></element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="bib26a"><label>(a)</label><person-group person-group-type="author"><name><surname>Das</surname><given-names>S.</given-names></name><name><surname>Mallick</surname><given-names>S.</given-names></name><name><surname>Sarka</surname><given-names>S.D.</given-names></name></person-group><article-title>Cobalt-catalyzed sustainable synthesis of benzimidazoles by redox-economical coupling of o-nitroanilines and alcohols</article-title><source>J.&#x000a0;Org. Chem.</source><volume>84</volume><year>2019</year><fpage>12111</fpage><lpage>12119</lpage><pub-id pub-id-type="pmid">31429563</pub-id></element-citation><element-citation publication-type="journal" id="bib26b"><label>(b)</label><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D.Y.</given-names></name><name><surname>Dao</surname><given-names>P.D.Q.</given-names></name><name><surname>Cho</surname><given-names>C.S.</given-names></name></person-group><article-title>Synthesis of pyrimidine- and quinazoline-fused benzimidazole-4,7- diones using combinatorial cyclocondensation and oxidation</article-title><source>ACS Omega</source><volume>3</volume><year>2018</year><fpage>17456</fpage><lpage>17465</lpage><pub-id pub-id-type="pmid">31458351</pub-id></element-citation><element-citation publication-type="journal" id="bib26c"><label>(c)</label><person-group person-group-type="author"><name><surname>Beytur</surname><given-names>Murat</given-names></name><name><surname>Irak</surname><given-names>Zeynep Turhan</given-names></name><name><surname>Manap</surname><given-names>Sevda</given-names></name><name><surname>Y&#x000fc;ksek</surname><given-names>Haydar</given-names></name></person-group><article-title>Synthesis, characterization and theoretical determination of corrosion inhibitor activities of some new 4,5-dihydro-1H-1,2,4-Triazol-5-one derivatives</article-title><source>Heliyon</source><volume>5</volume><year>2019</year><object-id pub-id-type="publisher-id">e01809</object-id></element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="journal" id="bib27a"><label>(a)</label><person-group person-group-type="author"><name><surname>Singhal</surname><given-names>S.</given-names></name><name><surname>Khanna</surname><given-names>P.</given-names></name><name><surname>Khanna</surname><given-names>L.</given-names></name></person-group><article-title>Synthesis, DFT studies, molecular docking, antimicrobial screening and UV fluorescence studies on ct-DNA for novel Schiff bases of 2-(1-aminobenzyl) benzimidazole</article-title><source>Heliyon</source><volume>5</volume><year>2019</year><object-id pub-id-type="publisher-id">e02596</object-id></element-citation><element-citation publication-type="journal" id="bib27b"><label>(b)</label><person-group person-group-type="author"><name><surname>Alam</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>D.U.</given-names></name></person-group><article-title>Synthesis, spectroscopic and computational studies of 2-(thiophen-2- yl)-2,3-dihydro-1H-perimidine: an enzymes inhibition study</article-title><source>Comput. Biol. Chem.</source><volume>64</volume><year>2016</year><fpage>185</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">27398906</pub-id></element-citation><element-citation publication-type="journal" id="bib27c"><label>(c)</label><person-group person-group-type="author"><name><surname>Mary</surname><given-names>Y.S.</given-names></name><name><surname>Mary</surname><given-names>Y.S.</given-names></name><name><surname>Resmi</surname><given-names>K.S.</given-names></name><name><surname>Thomas</surname><given-names>R.</given-names></name></person-group><article-title>DFT and molecular docking investigations of oxicam derivatives</article-title><source>Heliyon</source><volume>5</volume><year>2019</year><object-id pub-id-type="publisher-id">e02175</object-id></element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="book" id="bib28a"><label>(a)</label><person-group person-group-type="author"><name><surname>Frisch</surname><given-names>M.</given-names></name><name><surname>Trucks</surname><given-names>G.W.</given-names></name><name><surname>Schlegel</surname><given-names>H.B.</given-names></name><name><surname>Scuseria</surname><given-names>G.E.</given-names></name><name><surname>Robb</surname><given-names>M.A.</given-names></name><name><surname>Cheeseman</surname><given-names>J.R.</given-names></name><name><surname>Scalmani</surname><given-names>G.</given-names></name><name><surname>Barone</surname><given-names>V.</given-names></name><name><surname>Mennucci</surname><given-names>B.</given-names></name><name><surname>Petersson</surname><given-names>G.e.</given-names></name></person-group><chapter-title>Gaussian~ 09 Revision D. 01</chapter-title><year>2014</year></element-citation><element-citation publication-type="journal" id="bib28b"><label>(b)</label><person-group person-group-type="author"><name><surname>Singh</surname><given-names>A.</given-names></name><name><surname>Singh</surname><given-names>H.</given-names></name><name><surname>Khuranaa</surname><given-names>J.M.</given-names></name></person-group><article-title>Computational study of new 1,2,3-triazole derivative of lithocholic acid: structural aspects, non-linear optical properties and molecular docking studies as potential PTP 1B enzyme inhibitor</article-title><source>Comput. Biol. Chem.</source><volume>78</volume><year>2019</year><fpage>144</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">30521988</pub-id></element-citation><element-citation publication-type="journal" id="bib28c"><label>(c)</label><person-group person-group-type="author"><name><surname>Alama</surname><given-names>M.</given-names></name><name><surname>Alam</surname><given-names>M.J.</given-names></name><name><surname>Shaista</surname><given-names>A.</given-names></name><name><surname>Parveen</surname><given-names>M.</given-names></name><name><surname>Park</surname><given-names>S.</given-names></name><name><surname>Ahmad</surname><given-names>S.</given-names></name></person-group><article-title>DFT/TD-DFT calculations, spectroscopic characterizations (FTIR, NMR, UV&#x02013;vis), molecular docking and enzyme inhibition study of 7-benzoyloxycoumarin</article-title><source>Comput. Biol. Chem.</source><volume>73</volume><year>2018</year><fpage>65</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">29453141</pub-id></element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Roque</surname><given-names>J.M.</given-names></name><name><surname>Pandiyan</surname><given-names>T.</given-names></name><name><surname>Cruz</surname><given-names>J.</given-names></name><name><surname>Garc&#x00131;&#x000b4;a-Ochoa</surname><given-names>E.</given-names></name></person-group><article-title>DFT and electrochemical studies of tris(benzimidazole-2-ylmethyl)amine as an efficient corrosion inhibitor for carbon steel surface</article-title><source>Corrosion Sci.</source><volume>50</volume><year>2008</year><fpage>614</fpage><lpage>624</lpage></element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Mente&#x0015f;e</surname><given-names>E.</given-names></name><name><surname>Emirik</surname><given-names>M.</given-names></name><name><surname>S&#x000f6;kmen</surname><given-names>B.B.</given-names></name></person-group><article-title>Design, molecular docking and synthesis of novel 5,6-dichloro-2-methyl-1Hbenzimidazole derivatives as potential urease enzyme inhibitors</article-title><source><italic>B</italic>ioorg. Chem.</source><volume>8<bold>6</bold></volume><year>2019</year><fpage>151</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">30710848</pub-id></element-citation></ref></ref-list><sec id="appsec1" sec-type="supplementary-material"><label>Appendix A</label><title>Supplementary data</title><p id="p0240">The following is the supplementary data related to this article:<supplementary-material content-type="local-data" id="mmc1"><caption><title>supporting info october 1</title></caption><media xlink:href="mmc1.pdf"><alt-text>supporting info october 1</alt-text></media></supplementary-material></p></sec><ack id="ack0010"><title>Acknowledgements</title><p>We thank HEJ Karachi for High-Field NMR Center (HFNMRC) and Mass Spectrometry. We are also grateful to the HEC and Alama Iqbal Open University Pakistan for the lab facilities.</p></ack></back></article>